Description
Acadia Healthcare: A $3.31 Billion Growth Story Facing Operational Constraints!
Acadia Healthcare reported its fourth quarter and full-year 2025 financial results, demonstrating modest revenue growth and operational expansion amidst ongoing challenges. For the quarter, the company recorded $821.5 million in revenue, a 6.1% increase year-over-year, and adjusted EBITDA of $99.8 million. Full-year revenue reached $3.31 billion, a 5% increase that slightly surpassed the upper end of prior guidance, while adjusted EBITDA totaled $608.9 million, near the guidance range’s upper boundary. Growth was supported by a 4.4% same-facility revenue increase driven by higher patient days and revenue per patient day. The company expanded its capacity, adding 1,089 beds in 2025, exceeding guidance. Expansion was heavily weighted toward joint ventures with health systems and new de novo facilities, notably in the continued development of the company’s community treatment center (CTC) line, which provides a capital-efficient market entry. The outlook for 2026 projects additional bed growth between 400 and 600, revenue between $3.
